At the Market Issuance Sales AgreementAt the Market Issuance Sales Agreement • October 16th, 2013 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • New York
Ligand Pharmaceuticals Incorporated, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC (“MLV”), as follows:
LIGAND PHARMACEUTICALS INCORPORATED DOCS® ATM financing facility $24,000,000 of Common Stock, $0.001 par value SALES AGREEMENT October 11, 2013Sales Agreement • October 16th, 2013 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS SALES AGREEMENT (the “Agreement”) dated as of October 11, 2013 between Meyers Associates, L.P. (doing business as Brinson Patrick, a division of Meyers Associates, L.P.), having its principal office at 3 Columbus Circle, 15th Floor, New York, New York 10019 (the “Sales Manager”) and Ligand Pharmaceuticals Incorporated, a corporation organized and existing under the laws of the State of Delaware (the “Company”).
